Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome

Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome

Abstract Background Guillain-Barré syndrome (GBS) is an autoimmune disease that results in demyelination and axonal damage. Five percent of patients die and 20% remain significantly disabled on recovery. Recovery is slow in most cases and eventual disability is difficult to predict, especially early...

Full description

Bibliographic Details
Main Authors: Patrick Altmann, Desiree De Simoni, Alexandra Kaider, Birgit Ludwig, Jakob Rath, Fritz Leutmezer, Fritz Zimprich, Romana Hoeftberger, Michael P. Lunn, Amanda Heslegrave, Thomas Berger, Henrik Zetterberg, Paulus Stefan Rommer
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Journal of Neuroinflammation
Subjects:
Guillain-Barré syndrome
Biomarker
Neurofilament
Prognosis
Outcome
Online Access:http://link.springer.com/article/10.1186/s12974-020-01737-0

Internet

http://link.springer.com/article/10.1186/s12974-020-01737-0

Similar Items